Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
$1.16 -0.03 (-2.53%)
As of 02:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TLRY vs. ACB, CGC, CRON, OGI, SNDL, ABVX, AXSM, RNA, NUVL, and MRUS

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Abivax (ABVX), Axsome Therapeutics (AXSM), Avidity Biosciences (RNA), Nuvalent (NUVL), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry.

Tilray Brands vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

Aurora Cannabis has a net margin of -5.66% compared to Tilray Brands' net margin of -265.69%. Aurora Cannabis' return on equity of -1.49% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
Tilray Brands -265.69%-6.83%-5.45%

In the previous week, Tilray Brands had 13 more articles in the media than Aurora Cannabis. MarketBeat recorded 14 mentions for Tilray Brands and 1 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.60 beat Aurora Cannabis' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
3 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands has a consensus target price of $1.94, indicating a potential upside of 67.75%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.6% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.10$1.63M-$0.19-25.39
Tilray Brands$821.31M1.55-$2.19B-$2.31-0.50

Aurora Cannabis has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500.

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 17 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.27B$10.79B$5.75B$9.87B
Dividend YieldN/A1.84%6.66%4.49%
P/E Ratio-0.5021.6782.8226.56
Price / Sales1.5528.67500.42162.62
Price / Cash9.5525.1325.7028.92
Price / Book0.833.4010.796.50
Net Income-$2.19B$211.94M$3.28B$266.21M
7 Day Performance-21.43%-3.77%-0.25%-1.06%
1 Month Performance90.03%7.32%6.71%3.51%
1 Year Performance-30.42%-8.50%49.66%23.94%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
3.1661 of 5 stars
$1.16
-2.5%
$1.94
+67.7%
-29.5%$1.27B$821.31M-0.502,842Short Interest ↓
ACB
Aurora Cannabis
0.0972 of 5 stars
$5.20
-0.7%
N/A-15.9%$294.39M$246.72M-27.451,130
CGC
Canopy Growth
1.443 of 5 stars
$1.44
-0.3%
N/A-72.2%$344.18M$274.92M-0.473,150Positive News
Short Interest ↓
CRON
Cronos Group
1.657 of 5 stars
$2.52
-2.9%
N/A+12.9%$963.35M$117.61M50.30450
OGI
Organigram Global
1.2569 of 5 stars
$1.64
+0.4%
N/A-9.5%$219.31M$117.47M32.73860
SNDL
SNDL
3.4835 of 5 stars
$2.43
+1.0%
$4.00
+64.9%
+27.9%$639.86M$944.25M-9.022,516News Coverage
Analyst Forecast
Gap Down
ABVX
Abivax
2.4558 of 5 stars
$79.21
+2.3%
$92.33
+16.6%
+574.1%$5.99BN/A0.0061News Coverage
Positive News
Short Interest ↓
AXSM
Axsome Therapeutics
4.7788 of 5 stars
$118.75
+2.1%
$178.00
+49.9%
+36.1%$5.93B$385.69M-23.45380News Coverage
Positive News
Analyst Forecast
Insider Trade
RNA
Avidity Biosciences
3.2027 of 5 stars
$45.75
+1.1%
$67.00
+46.4%
+16.1%$5.90B$10.90M-12.89190Positive News
NUVL
Nuvalent
3.2422 of 5 stars
$74.87
+1.1%
$118.91
+58.8%
-4.9%$5.41BN/A-15.3040News Coverage
Positive News
Analyst Forecast
MRUS
Merus
3.0238 of 5 stars
$65.84
+0.1%
$88.75
+34.8%
+32.0%$4.99B$36.13M-12.0037News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners